Related Experiment Video
Updated: Oct 23, 2025
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding
Sandip Sarkar1, Tanmay Gokhale1, Subashini Kaliaperumal1
1Department of Ophthalmology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.
Abstract:
Rhino-orbital-cerebral mucormycosis is a life-threatening, opportunistic invasive fungal infection. Patients with moderate to severe coronavirus disease 2019 (COVID-19) infection are more vulnerable to it. Varied clinical presentations can be seen in patients with orbital mucormycosis starting from conjunctival chemosis, proptosis, ptosis, restriction of extraocular movements, exposure keratitis, neurotrophic keratitis, and central retinal artery occlusion. Exudative retinal detachment in a patient with orbital mucormycosis is a rare clinical entity. We, hereby, report a case of orbital mucormycosis with exudative retinal detachment in a patient post-COVID-19 infection.
Insights
A rare case of rhino-orbital-cerebral mucormycosis with exudative retinal detachment following COVID-19 infection is presented. This fungal infection poses a significant threat, particularly to severe COVID-19 patients.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Mycology
Background:
- Rhino-orbital-cerebral mucormycosis is a severe fungal infection.
- Patients with moderate to severe COVID-19 are at increased risk.
- Orbital mucormycosis presents with diverse ocular symptoms.
Observation:
- A patient developed exudative retinal detachment.
- This complication occurred post-COVID-19 infection.
- The patient had rhino-orbital-cerebral mucormycosis.
Findings:
- Orbital mucormycosis can lead to exudative retinal detachment.
- This presentation is rare in the context of COVID-19.
- Early recognition is crucial for management.
Implications:
- Highlights a rare but serious complication of COVID-19.
- Emphasizes the need for vigilance in diagnosing fungal infections post-COVID-19.
- Informs clinical practice regarding ocular manifestations of mucormycosis.
